Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure.
作者信息
Kim Nalee, Seong Jinsil
机构信息
Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
出版信息
Hepatobiliary Surg Nutr. 2022 Oct;11(5):770-772. doi: 10.21037/hbsn-22-330.
Abstract
摘要
相似文献
1
Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure.立体定向体部放射治疗与射频消融治疗肝细胞癌患者：并非竞争对手，而是治愈的伙伴。
Hepatobiliary Surg Nutr. 2022 Oct;11(5):770-772. doi: 10.21037/hbsn-22-330.
2
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.立体定向体部放疗与射频消融治疗亚洲肝细胞癌患者的比较。
J Hepatol. 2020 Jul;73(1):121-129. doi: 10.1016/j.jhep.2020.03.005. Epub 2020 Mar 10.
3
Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?在肝细胞癌患者中，比较立体定向体部放射治疗与射频消融时，索拉非尼的使用会影响结果吗？
J Hepatol. 2020 Aug;73(2):467-468. doi: 10.1016/j.jhep.2020.03.016. Epub 2020 May 11.
4
Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.立体定向体部放射治疗联合或不联合经动脉化疗栓塞术治疗无法进行手术切除或消融治疗的小肝癌患者的比较
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818783450. doi: 10.1177/1533033818783450.
5
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcinoma.立体定向消融体部放射治疗与手术和射频消融治疗两种患者队列的成本效益分析：转移性肝癌和肝细胞癌。
Clin Oncol (R Coll Radiol). 2021 Mar;33(3):e143-e154. doi: 10.1016/j.clon.2020.08.010. Epub 2020 Sep 18.
6
Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis.射频消融与立体定向体部放疗治疗小肝癌（≤3cm）：一项回顾性比较分析。
J Gastroenterol Hepatol. 2021 Jul;36(7):1962-1970. doi: 10.1111/jgh.15442. Epub 2021 Mar 5.
7
State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma.消融治疗肝癌的现状：根治性消融治疗的综述。
Future Oncol. 2017 Jul;13(16):1437-1448. doi: 10.2217/fon-2017-0061. Epub 2017 Jul 7.
8
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis.立体定向体部放射治疗与射频消融治疗小肝癌患者的系统评价和荟萃分析
Hepatobiliary Surg Nutr. 2021 Oct;10(5):623-630. doi: 10.21037/hbsn.2020.03.15.
9
Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?".回复：“在肝细胞癌患者中，比较立体定向体部放疗与射频消融时，索拉非尼的使用会影响结果吗？”
J Hepatol. 2020 Aug;73(2):468-469. doi: 10.1016/j.jhep.2020.04.016. Epub 2020 May 25.
10
Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?射频消融与立体定向体部放疗治疗肝细胞癌：是针锋相对还是相得益彰？
Int J Radiat Biol. 2021;97(2):111-119. doi: 10.1080/09553002.2021.1857453. Epub 2020 Dec 17.
引用本文的文献
1
Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based study.单纯消融术不劣于放疗联合消融术治疗早期肝细胞癌患者：一项基于人群的研究。
Sci Rep. 2024 Jan 10;14(1):1030. doi: 10.1038/s41598-024-51436-6.
本文引用的文献
1
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis.立体定向体部放射治疗与射频消融治疗小肝癌患者的系统评价和荟萃分析
Hepatobiliary Surg Nutr. 2021 Oct;10(5):623-630. doi: 10.21037/hbsn.2020.03.15.
2
Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.立体定向体部放疗治疗肝细胞癌的剂量反应关系：亚洲肝脏放疗协作组研究的汇总分析。
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):464-473. doi: 10.1016/j.ijrobp.2020.09.038. Epub 2020 Nov 20.
3
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.质子束放疗与射频消融治疗复发性肝细胞癌的随机 III 期试验。
J Hepatol. 2021 Mar;74(3):603-612. doi: 10.1016/j.jhep.2020.09.026. Epub 2020 Oct 5.
4
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.立体定向体部放疗与射频消融治疗亚洲肝细胞癌患者的比较。
J Hepatol. 2020 Jul;73(1):121-129. doi: 10.1016/j.jhep.2020.03.005. Epub 2020 Mar 10.
5
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study.立体定向体部放疗作为肝细胞癌射频消融不完全后的挽救性治疗：一项回顾性倾向评分匹配研究
Cancers (Basel). 2019 Aug 5;11(8):1116. doi: 10.3390/cancers11081116.
6
Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.放疗治疗肝细胞癌的生存结果与射频消融相当：一项倾向评分分析。
Hepatology. 2019 Jun;69(6):2533-2545. doi: 10.1002/hep.30591. Epub 2019 May 2.
7
Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.立体定向体部放射治疗与射频消融治疗肝细胞癌疗效的回顾性分析。
Radiother Oncol. 2019 Feb;131:81-87. doi: 10.1016/j.radonc.2018.12.013. Epub 2018 Dec 31.
8
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.射频消融与立体定向体部放疗治疗非手术管理患者局限性肝细胞癌的比较：国家癌症数据库分析。
J Clin Oncol. 2018 Feb 20;36(6):600-608. doi: 10.1200/JCO.2017.75.3228. Epub 2018 Jan 12.
9
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.
10
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
Zotero 插件